Filing Details
- Accession Number:
- 0001237899-18-000026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-20 17:36:43
- Reporting Period:
- 2018-12-19
- Accepted Time:
- 2018-12-20 17:36:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1697422 | R. Christopher Fenimore | 777 Old Saw Mill River Road Tarrytown NY 10591 | Vp Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-19 | 3,450 | $52.03 | 9,871 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-12-19 | 1,602 | $364.42 | 8,269 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2018-12-20 | 675 | $21.25 | 8,944 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-12-20 | 100 | $355.14 | 8,844 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-20 | 348 | $356.27 | 8,496 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-20 | 200 | $357.50 | 8,296 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-20 | 200 | $358.27 | 8,096 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-20 | 200 | $359.38 | 7,896 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-20 | 500 | $360.40 | 7,396 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-20 | 100 | $361.65 | 7,296 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-20 | 200 | $362.45 | 7,096 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2018-12-20 | 675 | $0.00 | 675 | $21.25 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2018-12-19 | 3,450 | $0.00 | 3,450 | $52.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 500 | 2019-12-18 | No | 4 | M | Direct | |
| 10,326 | 2021-12-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,349 | Indirect | By 401(k) Plan |
| Common Stock | 1,397 | Indirect | By Trust |
| Common Stock | 1,424 | Indirect | by 2017 GRAT |
| Common Stock | 2,950 | Indirect | by 2018 GRAT |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 348 shares of Company stock on December 20, 2018 at prices ranging from $356.22 to $356.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on December 20, 2018 at prices ranging from $357.15 to $357.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on December 20, 2018 at prices ranging from $358.18 to $358.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on December 20, 2018 at prices ranging from $359.18 to $359.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 2018 at each separate price.
- Represents volume-weighted average price of sales of 500 shares of Company stock on December 20, 2018 at prices ranging from $360.18 to $360.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on December 20, 2018 at prices ranging from $362.02 to $362.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2018 at each separate price.
- These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
